{"id":18666,"date":"2025-07-31T10:05:41","date_gmt":"2025-07-31T10:05:41","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=18666"},"modified":"2025-07-31T10:05:41","modified_gmt":"2025-07-31T10:05:41","slug":"protagenic-gets-japan-patent-for-stilbenoid-drug-program","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/","title":{"rendered":"\u30d7\u30ed\u30bf\u30b8\u30a7\u30cb\u30c3\u30af\u304c\u30b9\u30c6\u30a3\u30eb\u30d9\u30ce\u30a4\u30c9\u533b\u85ac\u54c1\u306e\u65e5\u672c\u7279\u8a31\u3092\u53d6\u5f97"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March 31, 2041. This patent underpins one of the Company&rsquo;s key pipeline assets, a modified stilbenoid, and importantly provides the Company with exclusivity to particular compounds per se, formulations containing a number of drug candidates, and their medical use, which is to treat epilepsy and seizures.<\/p><p>\u30b3\u30ea\u30f3\u30fb\u30b9\u30c8\u30c3\u30c8\u6700\u9ad8\u57f7\u884c\u8cac\u4efb\u8005 <a href=\"https:\/\/protagenic.com\/\" data-no-translation=\"\">Protagenic Therapeutics<\/a>, Inc. said: &ldquo;We are delighted to announce the grant of this important patent for the Company in Japan. Such a grant builds on the previous grant of the same patent in the UK (Patent GB2609814), and demonstrates the ability of the Company to continue its innovative approach and to add value and important protection to its development pipeline for shareholders. We anticipate being able to expand the grant of this patent in other territories in the future.&rdquo;<\/p><p>The Japanese pharmaceutical market is the world&rsquo;s third largest pharmaceutical market. In 2025, the Japanese pharmaceutical market is worth more than $85 billion US dollars, and the market size is anticipated to reach $93 billion US dollars by 2030.<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/infocom-launches-digipro-ai-compliance-tool-for-pharma\/\" rel=\"bookmark\">\u30a4\u30f3\u30d5\u30a9\u30b3\u30e0\u3001\u88fd\u85ac\u4f1a\u793e\u5411\u3051AI\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u30c4\u30fc\u30eb\u300cDigiPro\u300d\u3092\u767a\u8868<\/a><\/h4><p>\u3066\u3093\u304b\u3093\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834\u898f\u6a21\u306f\u30012024\u5e74\u306b\u306f$112.9\u5104\u7c73\u30c9\u30eb\u3068\u4e88\u6e2c\u3055\u308c\u30012034\u5e74\u306b\u306f\u7d04$187.4\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u30012025\u5e74\u304b\u30892034\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3044\u3066CAGR 5.20%\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p><p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/07\/30\/3124067\/0\/en\/Protagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.html\" data-no-translation=\"\">GlobeNewsWire<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March 31, 2041. This patent underpins one of the Company&rsquo;s key pipeline assets, a modified stilbenoid, and importantly provides the Company with exclusivity to particular compounds per se, formulations containing a number of drug candidates, and their medical use, which is to treat epilepsy and seizures.Colin Stott, Chief Operating Officer of Protagenic Therapeutics, Inc. said: &ldquo;We are delighted to announce the grant of this important patent for the Company in Japan. Such a grant builds on the previous grant of the same patent in the UK (Patent GB2609814), [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":18667,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[6711,1363,424,6712,6710],"ppma_author":[205],"class_list":["post-18666","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-health-tech","category-japan","category-news","category-pharma","category-regional","tag-epilepsy-drug-market","tag-health-tech","tag-pharma","tag-protagenic-therapeutics","tag-stilbenoid-program"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Protagenic Secures Japan Patent for Stilbenoid Candidates<\/title>\n<meta name=\"description\" content=\"Protagenic Therapeutics was granted Japan Patent JP 7714571B for its stilbenoid drug candidates, securing exclusivity for epilepsy treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Protagenic Secures Japan Patent for Stilbenoid Candidates\" \/>\n<meta property=\"og:description\" content=\"Protagenic Therapeutics was granted Japan Patent JP 7714571B for its stilbenoid drug candidates, securing exclusivity for epilepsy treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-31T10:05:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/rotagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30d7\u30ed\u30bf\u30b8\u30a7\u30cb\u30c3\u30af\u3001\u30b9\u30c1\u30eb\u30d9\u30ce\u30a4\u30c9\u5019\u88dc\u5316\u5408\u7269\u306e\u65e5\u672c\u7279\u8a31\u3092\u53d6\u5f97","description":"\u30d7\u30ed\u30bf\u30b8\u30a7\u30cb\u30c3\u30af\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u540c\u793e\u306e\u30b9\u30c1\u30eb\u30d9\u30ce\u30a4\u30c9\u7cfb\u85ac\u5264\u5019\u88dc\u306b\u3064\u3044\u3066\u3001\u3066\u3093\u304b\u3093\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306e\u72ec\u5360\u6a29\u3092\u78ba\u4fdd\u3057\u3001\u65e5\u672c\u7279\u8a31JP7714571B\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/","og_locale":"ja_JP","og_type":"article","og_title":"Protagenic Secures Japan Patent for Stilbenoid Candidates","og_description":"Protagenic Therapeutics was granted Japan Patent JP 7714571B for its stilbenoid drug candidates, securing exclusivity for epilepsy treatment.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/","og_site_name":"itbusinesstoday","article_published_time":"2025-07-31T10:05:41+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/rotagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"Protagenic Gets Japan Patent for Stilbenoid Drug Program","datePublished":"2025-07-31T10:05:41+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/"},"wordCount":241,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/rotagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.webp","keywords":["epilepsy drug market","Health tech","Pharma","Protagenic Therapeutics","Stilbenoid Program"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/","name":"\u30d7\u30ed\u30bf\u30b8\u30a7\u30cb\u30c3\u30af\u3001\u30b9\u30c1\u30eb\u30d9\u30ce\u30a4\u30c9\u5019\u88dc\u5316\u5408\u7269\u306e\u65e5\u672c\u7279\u8a31\u3092\u53d6\u5f97","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/rotagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.webp","datePublished":"2025-07-31T10:05:41+00:00","description":"\u30d7\u30ed\u30bf\u30b8\u30a7\u30cb\u30c3\u30af\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u540c\u793e\u306e\u30b9\u30c1\u30eb\u30d9\u30ce\u30a4\u30c9\u7cfb\u85ac\u5264\u5019\u88dc\u306b\u3064\u3044\u3066\u3001\u3066\u3093\u304b\u3093\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306e\u72ec\u5360\u6a29\u3092\u78ba\u4fdd\u3057\u3001\u65e5\u672c\u7279\u8a31JP7714571B\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/rotagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/rotagenic-Therapeutics-Announces-Grant-of-new-patent-in-Japan-for-its-Modified-Stilbenoid-Program-Drug-Candidates.webp","width":1200,"height":800,"caption":"Protagenic Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/protagenic-gets-japan-patent-for-stilbenoid-drug-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Protagenic Gets Japan Patent for Stilbenoid Drug Program"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"author_category":"","first_name":"NewsDesk","last_name":"","user_url":"https:\/\/itbusinesstoday.com","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/18666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=18666"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/18666\/revisions"}],"predecessor-version":[{"id":18668,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/18666\/revisions\/18668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/18667"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=18666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=18666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=18666"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=18666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}